Literature DB >> 8968090

Induction of cell growth regulatory genes by p53.

S L Madden1, E A Galella, D Riley, A H Bertelsen, G A Beaudry.   

Abstract

Transcriptionally regulated growth-response genes play a pivotal role in the determination of the fate of a cell. p53 is known to transcriptionally regulate genes important in regulating cell growth potential. Using differential reverse transcription-PCR analysis of rat embryo fibroblast cells containing a temperature-sensitive p53 allele, we were able to isolate several transcripts up-regulated specifically in cells harboring functional p53 protein. Two of these genes, SM20 and microsomal epoxide hydrolase (mEH), are previously described genes. Two previously uncharacterized cDNAs, cell growth regulatory (CGR) genes CGR11 and CGR19, were isolated. The predicted amino acid sequence of these novel proteins contain known motifs; EF-hand domains (CGR11) and a ring-finger domain (CGR19), suggestive of function. CGR11 and CGR19 appear to be primary response genes expressed to moderate levels in functional p53 cells. Both CGR11 and CGR19 are able to inhibit the growth of several cell lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968090

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

Review 2.  The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.

Authors:  Edurne Berra; Amandine Ginouvès; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

3.  p21 delays tumor onset by preservation of chromosomal stability.

Authors:  Juan A Barboza; Geng Liu; Zhenlin Ju; Adel K El-Naggar; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

4.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

5.  ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.

Authors:  M You; P T Ku; R Hrdlicková; H R Bose
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.

Authors:  Hannah X Chu; Nicole M Jones
Journal:  Neurochem Res       Date:  2015-06-25       Impact factor: 3.996

7.  A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse.

Authors:  Gilles Ponzio; Roger Rezzonico; Isabelle Bourget; Richard Allan; Nicolas Nottet; Alexandra Popa; Virginie Magnone; Géraldine Rios; Bernard Mari; Pascal Barbry
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

8.  Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.

Authors:  Jian-Hua Luo; Ying Ding; Rui Chen; George Michalopoulos; Joel Nelson; George Tseng; Yan P Yu
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

9.  EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.

Authors:  Jian Fu; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

Review 10.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.